1,2-dichloroethane decreases expression ISO RGD:62257 6480464 ethylene dichloride results in decreased expression of GSTM3 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:62257 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GSTM5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:62257 6480464 1, 2-Dimethylhydrazine results in decreased expression of GSTM3 mRNA CTD PMID:22206623 1,4-dioxane increases expression ISO RGD:62257 6480464 1, 4-dioxane results in increased expression of GSTM3 mRNA CTD PMID:33693819 1-chloro-2,4-dinitrobenzene increases metabolic processing ISO RGD:1349768 6480464 GSTM3 protein polymorphism results in increased metabolism of Dinitrochlorobenzene CTD PMID:15247628 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:62257 6480464 Dinitrochlorobenzene results in decreased expression of GSTM3 mRNA CTD PMID:21404309 1-chloro-2,4-dinitrobenzene affects metabolic processing ISO RGD:62257 6480464 GSTM5 protein affects the metabolism of Dinitrochlorobenzene CTD PMID:9545290 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of GSTM3 protein CTD PMID:9794801 1-chloro-2,4-dinitrobenzene affects metabolic processing EXP 6480464 GSTM3 protein affects the metabolism of Dinitrochlorobenzene CTD PMID:3169012 1-chloro-2,4-dinitrobenzene affects metabolic processing ISO RGD:1349768 6480464 GSTM3 protein affects the metabolism of Dinitrochlorobenzene CTD PMID:9545290 1-chloro-2,4-dinitrobenzene decreases metabolic processing ISO RGD:1349768 6480464 GSTM3 protein polymorphism results in decreased metabolism of Dinitrochlorobenzene CTD PMID:15247628 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of GSTM3 mRNA CTD PMID:17522070 1-naphthyl isothiocyanate multiple interactions ISO RGD:62257 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GSTM3 mRNA, [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GSTM3 mRNA CTD PMID:33749747 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GSTM3 mRNA CTD PMID:30723492 1-naphthyl isothiocyanate increases expression ISO RGD:62257 6480464 1-Naphthylisothiocyanate results in increased expression of GSTM3 mRNA, 1-Naphthylisothiocyanate results in increased expression of GSTM5 mRNA CTD PMID:15913567 more ... 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GSTM3 mRNA CTD PMID:15576828 more ... 17alpha-ethynylestradiol decreases expression ISO RGD:62257 6480464 Ethinyl Estradiol results in decreased expression of GSTM3 mRNA, Ethinyl Estradiol results in decreased expression of GSTM5 mRNA CTD PMID:14976129 , PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:62257 6480464 Ethinyl Estradiol affects the expression of GSTM3 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:62257 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GSTM3 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GSTM5 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1349768 6480464 Estradiol results in increased expression of GSTM3 mRNA CTD PMID:11331657 17beta-estradiol decreases expression ISO RGD:62257 6480464 Estradiol results in decreased expression of GSTM3 mRNA CTD PMID:14664709 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GSTM3 mRNA CTD PMID:17522070 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:62257 6480464 [2 more ... CTD PMID:23457121 , PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1349768 6480464 Tetrachlorodibenzodioxin results in decreased expression of GSTM3 mRNA CTD PMID:16039398 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62257 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA CTD PMID:18172886 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62257 6480464 Tetrachlorodibenzodioxin affects the expression of GSTM3 mRNA, Tetrachlorodibenzodioxin affects the expression of GSTM5 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62257 6480464 Tetrachlorodibenzodioxin results in decreased expression of GSTM3 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62257 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of GSTM3 mRNA more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA CTD PMID:21215274 2,4,6-tribromophenol increases expression ISO RGD:1349768 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of GSTM3 mRNA CTD PMID:21346803 2,6-dichloroindophenol multiple interactions ISO RGD:1349768 6480464 [2, 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GSTM3 mRNA CTD PMID:21034357 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of GSTM3 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:62257 6480464 n-butoxyethanol results in increased expression of GSTM5 mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO RGD:1349768 6480464 Lactic Acid results in decreased expression of GSTM3 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:62257 6480464 3 more ... CTD PMID:24378064 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:62257 6480464 3 more ... CTD PMID:18723825 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:62257 6480464 Sunphenon promotes the reaction [3 more ... CTD PMID:24378064 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1349768 6480464 tetrabromobisphenol A results in decreased expression of GSTM3 protein CTD PMID:31675489 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of GSTM3 protein CTD PMID:26072098 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of GSTM3 protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1349768 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GSTM3 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GSTM3 mRNA CTD PMID:30723492 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:62257 6480464 Oxazolone results in decreased expression of GSTM3 mRNA CTD PMID:21404309 4-hydroxyphenyl retinamide increases expression ISO RGD:62257 6480464 Fenretinide results in increased expression of GSTM3 mRNA, Fenretinide results in increased expression of GSTM5 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:62257 6480464 Fenretinide results in decreased expression of GSTM5 mRNA CTD PMID:16467112 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1349768 6480464 [Decitabine affects the methylation of GSTM3 promoter] which affects the expression of GSTM3 mRNA CTD PMID:18664505 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:62257 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GSTM3 mRNA CTD PMID:33749747 acetamide increases expression EXP 6480464 acetamide results in increased expression of GSTM3 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:62257 6480464 Aflatoxin B1 results in decreased expression of GSTM3 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GSTM3 mRNA CTD PMID:33354967 all-trans-retinoic acid increases expression ISO RGD:1349768 6480464 Tretinoin results in increased expression of GSTM3 mRNA CTD PMID:21934132 allopurinol multiple interactions ISO RGD:62257 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GSTM3 mRNA CTD PMID:33749747 alpha-Zearalanol increases expression ISO RGD:1349768 6480464 Zeranol results in increased expression of GSTM3 mRNA CTD PMID:11331657 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GSTM3 mRNA CTD PMID:16483693 amphibole asbestos affects expression ISO RGD:1349768 6480464 Asbestos, Amphibole affects the expression of GSTM3 protein CTD PMID:20855422 andrographolide increases expression ISO RGD:62257 6480464 andrographolide results in increased expression of GSTM3 mRNA CTD PMID:19737545 andrographolide multiple interactions ISO RGD:62257 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA CTD PMID:19737545 angelica lactone increases expression ISO RGD:62257 6480464 angelica lactone results in increased expression of GSTM5 protein CTD PMID:11309284 aristolochic acid increases expression EXP 6480464 aristolochic acid I results in increased expression of GSTM3 mRNA CTD PMID:17483316 aristolochic acid increases expression ISO RGD:1349768 6480464 aristolochic acid I results in increased expression of GSTM3 protein CTD PMID:33212167 arsane increases expression ISO RGD:1349768 6480464 Arsenic results in increased expression of GSTM3 mRNA CTD PMID:19945496 arsane affects methylation ISO RGD:1349768 6480464 Arsenic affects the methylation of GSTM3 gene CTD PMID:25304211 arsenic atom increases expression ISO RGD:1349768 6480464 Arsenic results in increased expression of GSTM3 mRNA CTD PMID:19945496 arsenic atom affects methylation ISO RGD:1349768 6480464 Arsenic affects the methylation of GSTM3 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:1349768 6480464 arsenite promotes the reaction [G3BP1 protein binds to GSTM3 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1349768 6480464 Arsenic Trioxide results in increased expression of GSTM3 mRNA CTD PMID:22521957 asbestos affects expression ISO RGD:1349768 6480464 Asbestos affects the expression of GSTM3 protein CTD PMID:7614465 atrazine multiple interactions ISO RGD:62257 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA CTD PMID:22515965 atrazine increases expression EXP 6480464 Atrazine results in increased expression of GSTM3 mRNA CTD PMID:28882082 benzo[a]pyrene decreases expression ISO RGD:1349768 6480464 Benzo(a)pyrene results in decreased expression of GSTM3 protein CTD PMID:22138271 benzo[a]pyrene decreases methylation ISO RGD:1349768 6480464 Benzo(a)pyrene results in decreased methylation of GSTM3 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:62257 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of GSTM5 mRNA CTD PMID:25820237 benzo[a]pyrene increases expression ISO RGD:62257 6480464 Benzo(a)pyrene results in increased expression of GSTM3 mRNA, Benzo(a)pyrene results in increased expression of GSTM5 mRNA CTD PMID:21569818 more ... benzo[a]pyrene multiple interactions ISO RGD:1349768 6480464 Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSTM3 protein] CTD PMID:22138271 benzo[a]pyrene increases expression ISO RGD:1349768 6480464 Benzo(a)pyrene results in increased expression of GSTM3 mRNA CTD PMID:20064835 benzyl isothiocyanate increases expression EXP 6480464 benzyl isothiocyanate results in increased expression of GSTM3 protein CTD PMID:9794803 beta-naphthoflavone multiple interactions ISO RGD:62257 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA CTD PMID:19737545 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of GSTM3 protein CTD PMID:9794803 bifenthrin increases expression ISO RGD:62257 6480464 bifenthrin results in increased expression of GSTM5 mRNA CTD PMID:26071804 bis(2-chloroethyl) sulfide decreases expression ISO RGD:62257 6480464 Mustard Gas results in decreased expression of GSTM5 mRNA CTD PMID:18955075 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:62257 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 , PMID:28433925 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1349768 6480464 Diethylhexyl Phthalate results in decreased expression of GSTM3 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:62257 6480464 Diethylhexyl Phthalate results in increased expression of GSTM3 mRNA, Diethylhexyl Phthalate results in increased expression of GSTM5 mRNA CTD PMID:19850644 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GSTM3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:62257 6480464 bisphenol A results in increased expression of GSTM3 mRNA CTD PMID:33221593 bisphenol A multiple interactions ISO RGD:62257 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol F multiple interactions ISO RGD:1349768 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GSTM3 mRNA CTD PMID:28628672 butanal increases expression ISO RGD:1349768 6480464 butyraldehyde results in increased expression of GSTM3 mRNA CTD PMID:26079696 butylated hydroxyanisole increases expression ISO RGD:62257 6480464 Butylated Hydroxyanisole results in increased expression of GSTM3 mRNA more ... CTD PMID:11309284 more ... butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of GSTM3 protein CTD PMID:9794803 cadmium atom increases expression ISO RGD:1349768 6480464 Cadmium results in increased expression of GSTM3 mRNA CTD PMID:24376830 cadmium dichloride increases expression ISO RGD:1349768 6480464 Cadmium Chloride results in increased expression of GSTM3 protein CTD PMID:24527689 cafestol multiple interactions ISO RGD:62257 6480464 [cafestol co-treated with kahweol palmitate] results in increased expression of GSTM5 protein CTD PMID:11309284 captan increases expression ISO RGD:62257 6480464 Captan results in increased expression of GSTM3 mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:62257 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1349768 6480464 Nanotubes, Carbon results in decreased expression of GSTM3 protein CTD PMID:22157353 carbon nanotube affects expression ISO RGD:1349768 6480464 Nanotubes, Carbon affects the expression of GSTM3 protein CTD PMID:22001959 carbon nanotube decreases expression ISO RGD:62257 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO RGD:1349768 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of GSTM3 mRNA CTD PMID:16039398 carmustine multiple interactions ISO RGD:1349768 6480464 GSTM3 protein results in decreased nitrosation of and results in decreased activity of Carmustine CTD PMID:8395980 carmustine affects metabolic processing ISO RGD:1349768 6480464 GSTM3 protein affects the metabolism of Carmustine CTD PMID:15247628 carmustine decreases nitrosation ISO RGD:1349768 6480464 GSTM3 protein results in decreased nitrosation of Carmustine CTD PMID:11841793 chlordecone increases expression ISO RGD:62257 6480464 Chlordecone results in increased expression of GSTM5 mRNA CTD PMID:33711761 chloroform decreases expression EXP 6480464 Chloroform results in decreased expression of GSTM3 mRNA CTD PMID:17522070 chloroprene increases expression ISO RGD:62257 6480464 Chloroprene results in increased expression of GSTM3 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of GSTM3 mRNA CTD PMID:17452286 chlorpyrifos decreases expression ISO RGD:1349768 6480464 Chlorpyrifos results in decreased expression of GSTM3 mRNA CTD PMID:33011216 chlorpyrifos multiple interactions ISO RGD:62257 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA CTD PMID:22515965 cholic acid increases expression ISO RGD:62257 6480464 Cholic Acid results in increased expression of GSTM3 mRNA CTD PMID:17521389 choline multiple interactions ISO RGD:62257 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GSTM5 gene CTD PMID:20938992 , PMID:33549593 chromium(6+) multiple interactions ISO RGD:62257 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of GSTM5 mRNA CTD PMID:25820237 ciguatoxin CTX1B affects expression ISO RGD:62257 6480464 Ciguatoxins affects the expression of GSTM5 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1349768 6480464 Cisplatin results in increased expression of GSTM3 mRNA CTD PMID:27594783 cisplatin affects response to substance ISO RGD:1349768 6480464 GSTM3 gene polymorphism affects the susceptibility to Cisplatin, GSTM3 protein affects the susceptibility to Cisplatin CTD PMID:11081456 , PMID:16217747 clobetasol increases expression ISO RGD:62257 6480464 Clobetasol results in increased expression of GSTM5 mRNA CTD PMID:27462272 clofibrate increases expression ISO RGD:62257 6480464 Clofibrate results in increased expression of GSTM3 mRNA, Clofibrate results in increased expression of GSTM5 mRNA CTD PMID:18723825 , PMID:22496397 clofibrate multiple interactions ISO RGD:62257 6480464 PPARA protein affects the reaction [Clofibrate results in increased expression of GSTM3 mRNA] CTD PMID:22496397 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of GSTM3 mRNA CTD PMID:17602206 cobalt atom increases expression ISO RGD:62257 6480464 Cobalt results in increased expression of GSTM3 mRNA CTD PMID:22147119 copper atom multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA, [Copper co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA CTD PMID:20302851 copper atom multiple interactions ISO RGD:1349768 6480464 [Chelating Agents binds to Copper] which results in increased expression of GSTM3 mRNA CTD PMID:30911355 copper atom increases expression EXP 6480464 Copper results in increased expression of GSTM3 mRNA CTD PMID:30556269 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA, [Copper co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA CTD PMID:20302851 copper(0) multiple interactions ISO RGD:1349768 6480464 [Chelating Agents binds to Copper] which results in increased expression of GSTM3 mRNA CTD PMID:30911355 copper(0) increases expression EXP 6480464 Copper results in increased expression of GSTM3 mRNA CTD PMID:30556269 coumarin increases expression EXP 6480464 coumarin results in increased expression of GSTM3 protein CTD PMID:9794803 coumarin increases expression ISO RGD:62257 6480464 coumarin results in increased expression of GSTM5 protein CTD PMID:11309284 cumene hydroperoxide increases metabolic processing ISO RGD:1349768 6480464 GSTM3 protein polymorphism results in increased metabolism of cumene hydroperoxide CTD PMID:15247628 cumene hydroperoxide decreases metabolic processing ISO RGD:1349768 6480464 GSTM3 protein polymorphism results in decreased metabolism of cumene hydroperoxide CTD PMID:15247628 cyanocob(III)alamin multiple interactions ISO RGD:62257 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA CTD PMID:33549593 cyclosporin A decreases expression ISO RGD:62257 6480464 Cyclosporine results in decreased expression of GSTM3 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1349768 6480464 Cyclosporine results in decreased expression of GSTM3 mRNA CTD PMID:25562108 , PMID:27989131 cylindrospermopsin increases expression ISO RGD:1349768 6480464 cylindrospermopsin results in increased expression of GSTM3 mRNA CTD PMID:23726867 cylindrospermopsin increases expression ISO RGD:62257 6480464 cylindrospermopsin results in increased expression of GSTM5 mRNA CTD PMID:20936652 cyproconazole increases expression ISO RGD:62257 6480464 cyproconazole results in increased expression of GSTM3 mRNA CTD PMID:22334560 , PMID:23970803 D-penicillamine increases expression ISO RGD:1349768 6480464 Penicillamine results in increased expression of GSTM3 mRNA CTD PMID:22843330 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of GSTM3 mRNA CTD PMID:17522070 dexamethasone multiple interactions ISO RGD:1349768 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GSTM3 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:62257 6480464 Dexamethasone results in increased expression of GSTM3 mRNA, Dexamethasone results in increased expression of GSTM5 mRNA CTD PMID:18723825 , PMID:21041162 dextran sulfate multiple interactions ISO RGD:62257 6480464 Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GSTM3 protein] CTD PMID:32272095 dextran sulfate decreases expression ISO RGD:62257 6480464 Dextran Sulfate results in decreased expression of GSTM3 protein CTD PMID:32272095 Diallyl sulfide increases expression ISO RGD:62257 6480464 allyl sulfide results in increased expression of GSTM3 mRNA CTD PMID:18723825 diarsenic trioxide increases expression ISO RGD:1349768 6480464 Arsenic Trioxide results in increased expression of GSTM3 mRNA CTD PMID:22521957 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of GSTM3 mRNA CTD PMID:17452286 , PMID:19440498 diazinon increases methylation ISO RGD:1349768 6480464 Diazinon results in increased methylation of GSTM3 gene CTD PMID:22964155 dibenzoylmethane multiple interactions ISO RGD:62257 6480464 [sulforaphane co-treated with dibenzoylmethane] results in increased expression of GSTM3 mRNA CTD PMID:17942926 dibenzoylmethane increases expression ISO RGD:62257 6480464 dibenzoylmethane results in increased expression of GSTM3 mRNA CTD PMID:17942926 dichloroacetic acid increases expression ISO RGD:62257 6480464 Dichloroacetic Acid results in increased expression of GSTM3 mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:62257 6480464 Diclofenac results in increased expression of GSTM3 mRNA CTD PMID:26934552 dicrotophos decreases expression ISO RGD:1349768 6480464 dicrotophos results in decreased expression of GSTM3 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of GSTM3 mRNA CTD PMID:19440498 diethylstilbestrol increases expression ISO RGD:1349768 6480464 Diethylstilbestrol results in increased expression of GSTM3 mRNA CTD PMID:11331657 dimethylarsinic acid increases expression ISO RGD:62257 6480464 Cacodylic Acid results in increased expression of GSTM5 mRNA CTD PMID:15345372 dimethylarsinous acid increases expression ISO RGD:1349768 6480464 dimethylarsinous acid results in increased expression of GSTM3 mRNA CTD PMID:20886546 dinophysistoxin 1 increases expression ISO RGD:1349768 6480464 dinophysistoxin 1 results in increased expression of GSTM3 mRNA CTD PMID:28939011 disodium selenite increases expression ISO RGD:1349768 6480464 Sodium Selenite results in increased expression of GSTM3 mRNA CTD PMID:24383545 doramapimod increases expression ISO RGD:62257 6480464 doramapimod results in increased expression of GSTM3 mRNA CTD PMID:21328587 dorsomorphin multiple interactions ISO RGD:1349768 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTM3 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:62257 6480464 Doxorubicin results in increased expression of GSTM3 mRNA CTD PMID:26873546 doxorubicin decreases expression ISO RGD:1349768 6480464 Doxorubicin results in decreased expression of GSTM3 mRNA CTD PMID:29803840 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of GSTM3 protein CTD PMID:28818578 emodin decreases expression ISO RGD:1349768 6480464 Emodin results in decreased expression of GSTM3 mRNA CTD PMID:16045814 endosulfan increases expression ISO RGD:62257 6480464 Endosulfan results in increased expression of GSTM3 mRNA CTD PMID:22515965 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GSTM3 mRNA CTD PMID:29391264 endosulfan multiple interactions ISO RGD:62257 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA CTD PMID:22515965 enzyme inhibitor multiple interactions ISO RGD:1349768 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GSTM3 protein CTD PMID:23301498 epoxiconazole increases expression ISO RGD:62257 6480464 epoxiconazole results in increased expression of GSTM3 mRNA CTD PMID:22334560 , PMID:23970803 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of GSTM3 mRNA CTD PMID:17522070 ethanol increases expression EXP 6480464 Ethanol results in increased expression of GSTM3 mRNA CTD PMID:16098508 ethanol increases expression ISO RGD:62257 6480464 Ethanol results in increased expression of GSTM3 mRNA CTD PMID:19167417 ethanol multiple interactions ISO RGD:62257 6480464 Ethanol affects the expression of and affects the splicing of GSTM5 mRNA CTD PMID:30319688 ethoxyquin increases expression ISO RGD:62257 6480464 Ethoxyquin results in increased expression of GSTM3 mRNA, Ethoxyquin results in increased expression of GSTM5 protein CTD PMID:11309284 , PMID:18723825 ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of GSTM3 protein CTD PMID:9794803 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA CTD PMID:18253720 , PMID:18775883 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of GSTM3 mRNA CTD PMID:18775883 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of GSTM3 mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GSTM3 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:62257 6480464 [1 more ... CTD PMID:20938992 more ... folpet increases expression ISO RGD:62257 6480464 folpet results in increased expression of GSTM3 mRNA CTD PMID:31558096 fumonisin B1 increases expression ISO RGD:62257 6480464 fumonisin B1 results in increased expression of GSTM3 mRNA CTD PMID:16221962 furan increases expression ISO RGD:62257 6480464 furan results in increased expression of GSTM3 mRNA CTD PMID:20194422 gliclazide multiple interactions EXP 6480464 Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] CTD PMID:21439372 glutathione affects metabolic processing ISO RGD:1349768 6480464 GSTM3 protein affects the metabolism of Glutathione CTD PMID:9545290 glutathione affects metabolic processing ISO RGD:62257 6480464 GSTM5 protein affects the metabolism of Glutathione CTD PMID:9545290 glycine betaine multiple interactions ISO RGD:62257 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA CTD PMID:33549593 graphite decreases expression ISO RGD:1349768 6480464 Graphite results in decreased expression of GSTM3 protein CTD PMID:22157353 GW 4064 increases expression ISO RGD:62257 6480464 GW 4064 results in increased expression of GSTM3 mRNA CTD PMID:26655953 homocysteine multiple interactions ISO RGD:1349768 6480464 [Methionine deficiency co-treated with Homocysteine] affects the expression of GSTM3 protein CTD PMID:17116298 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA, [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA CTD PMID:22129741 , PMID:24418717 indole-3-methanol increases expression ISO RGD:62257 6480464 indole-3-carbinol results in increased expression of GSTM5 protein CTD PMID:11309284 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of GSTM3 mRNA, indole-3-carbinol results in increased expression of GSTM3 protein CTD PMID:24418717 , PMID:9794803 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GSTM3 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1349768 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GSTM3 mRNA CTD PMID:28628672 iron atom multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA CTD PMID:20302851 iron(0) multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA CTD PMID:20302851 ivermectin decreases expression ISO RGD:1349768 6480464 Ivermectin results in decreased expression of GSTM3 protein CTD PMID:32959892 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA, [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA CTD PMID:18544905 kojic acid multiple interactions ISO RGD:62257 6480464 [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA CTD PMID:17917374 L-methionine multiple interactions ISO RGD:1349768 6480464 [Methionine deficiency co-treated with Homocysteine] affects the expression of GSTM3 protein, Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSTM3 protein] CTD PMID:17116298 , PMID:22138271 L-methionine multiple interactions ISO RGD:62257 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GSTM5 gene CTD PMID:20938992 , PMID:33549593 lipopolysaccharide decreases expression ISO RGD:62257 6480464 Lipopolysaccharides results in decreased expression of GSTM3 mRNA CTD PMID:27339419 lithium atom increases expression EXP 6480464 Lithium results in increased expression of GSTM3 mRNA CTD PMID:18082333 lithium chloride multiple interactions ISO RGD:62257 6480464 [Lithium Chloride results in increased activity of CTNNB1 protein] which results in increased expression of GSTM3 mRNA CTD PMID:20118494 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of GSTM3 mRNA CTD PMID:18082333 medroxyprogesterone acetate increases expression ISO RGD:1349768 6480464 Medroxyprogesterone Acetate results in increased expression of GSTM3 mRNA CTD PMID:18497975 mefenamic acid increases glutathionylation ISO RGD:1349768 6480464 GSTM3 protein results in increased glutathionylation of Mefenamic Acid analog CTD PMID:25372302 methylmercury chloride decreases expression ISO RGD:62257 6480464 methylmercuric chloride results in decreased expression of GSTM5 mRNA CTD PMID:20061341 microcystin affects expression EXP 6480464 Microcystins affects the expression of GSTM3 mRNA CTD PMID:19790251 microcystin decreases expression EXP 6480464 Microcystins results in decreased expression of GSTM3 mRNA CTD PMID:19790251 microcystin-LR increases expression ISO RGD:62257 6480464 cyanoginosin LR results in increased expression of GSTM3 mRNA, cyanoginosin LR results in increased expression of GSTM5 mRNA CTD PMID:17654400 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of GSTM3 mRNA CTD PMID:34740672 monocrotaline multiple interactions ISO RGD:62257 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA CTD PMID:21224054 monosodium L-glutamate increases expression ISO RGD:62257 6480464 Sodium Glutamate results in increased expression of GSTM3 mRNA CTD PMID:19001666 , PMID:25473020 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:62257 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GSTM3 mRNA, benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GSTM5 mRNA CTD PMID:20061341 N-nitrosodiethylamine multiple interactions ISO RGD:62257 6480464 [2 more ... CTD PMID:17917374 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of GSTM3 mRNA CTD PMID:14965361 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of GSTM3 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA more ... CTD PMID:18253720 more ... naloxone decreases expression EXP 6480464 Naloxone results in decreased expression of GSTM3 mRNA CTD PMID:17522070 naphthalene increases expression ISO RGD:62257 6480464 naphthalene results in increased expression of GSTM5 mRNA CTD PMID:31020322 naphthalene affects expression ISO RGD:62257 6480464 naphthalene affects the expression of GSTM3 mRNA CTD PMID:31020322 nickel atom affects expression ISO RGD:1349768 6480464 Nickel affects the expression of GSTM3 mRNA CTD PMID:14575637 nickel atom decreases expression ISO RGD:1349768 6480464 Nickel results in decreased expression of GSTM3 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom affects expression EXP 6480464 Nickel affects the expression of GSTM3 mRNA CTD PMID:19440498 nickel atom multiple interactions ISO RGD:1349768 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of GSTM3 mRNA] CTD PMID:14575637 nicotinamide multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA more ... CTD PMID:21439372 non-2-enal increases metabolic processing ISO RGD:1349768 6480464 GSTM3 protein polymorphism results in increased metabolism of 2-nonenal CTD PMID:15247628 non-2-enal decreases metabolic processing ISO RGD:1349768 6480464 GSTM3 protein polymorphism results in decreased metabolism of 2-nonenal CTD PMID:15247628 ochratoxin A increases acetylation ISO RGD:1349768 6480464 ochratoxin A results in increased acetylation of GSTM3 promoter CTD PMID:29098329 ochratoxin A decreases expression ISO RGD:1349768 6480464 ochratoxin A results in decreased expression of GSTM3 mRNA CTD PMID:32905824 ochratoxin A multiple interactions ISO RGD:1349768 6480464 [ochratoxin A results in increased acetylation of GSTM3 promoter] which results in increased expression of GSTM3 mRNA CTD PMID:29098329 ochratoxin A increases expression ISO RGD:1349768 6480464 ochratoxin A results in increased expression of GSTM3 mRNA CTD PMID:29098329 okadaic acid increases expression ISO RGD:1349768 6480464 Okadaic Acid results in increased expression of GSTM3 mRNA CTD PMID:28939011 oltipraz increases expression ISO RGD:62257 6480464 oltipraz results in increased expression of GSTM3 mRNA CTD PMID:18723825 , PMID:22496397 oltipraz increases expression EXP 6480464 oltipraz results in increased expression of GSTM3 protein CTD PMID:9794803 oltipraz multiple interactions ISO RGD:62257 6480464 [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTM3 mRNA, NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTM3 mRNA] CTD PMID:22496397 orphenadrine multiple interactions EXP 6480464 [Orphenadrine co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA, [Phenobarbital co-treated with Orphenadrine] affects the expression of GSTM3 mRNA CTD PMID:23665939 , PMID:23665940 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of GSTM3 mRNA CTD PMID:23665940 ozone decreases expression ISO RGD:62257 6480464 Ozone results in decreased expression of GSTM3 mRNA CTD PMID:12763052 paracetamol affects expression ISO RGD:62257 6480464 Acetaminophen affects the expression of GSTM5 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:62257 6480464 Acetaminophen results in decreased expression of GSTM3 mRNA CTD PMID:16611625 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GSTM3 mRNA CTD PMID:17522070 paraquat increases expression ISO RGD:1349768 6480464 Paraquat results in increased expression of GSTM3 mRNA CTD PMID:20883675 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GSTM3 mRNA CTD PMID:32680482 paraquat increases expression ISO RGD:62257 6480464 Paraquat results in increased expression of GSTM3 mRNA CTD PMID:16128001 paraquat affects expression ISO RGD:62257 6480464 Paraquat affects the expression of GSTM5 mRNA CTD PMID:27788593 pentachlorophenol increases expression ISO RGD:62257 6480464 Pentachlorophenol results in increased expression of GSTM3 mRNA CTD PMID:23892564 pentanal increases expression ISO RGD:1349768 6480464 pentanal results in increased expression of GSTM3 mRNA CTD PMID:26079696 perfluorohexanesulfonic acid increases expression ISO RGD:62257 6480464 perfluorohexanesulfonic acid results in increased expression of GSTM3 mRNA CTD PMID:28558994 perfluorononanoic acid increases expression ISO RGD:62257 6480464 perfluoro-n-nonanoic acid results in increased expression of GSTM3 mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:62257 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of GSTM3 mRNA more ... CTD PMID:25949234 more ... perfluorooctane-1-sulfonic acid decreases expression ISO RGD:62257 6480464 perfluorooctane sulfonic acid results in decreased expression of GSTM3 mRNA CTD PMID:26300304 perfluorooctane-1-sulfonic acid affects expression ISO RGD:62257 6480464 perfluorooctane sulfonic acid affects the expression of GSTM3 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:62257 6480464 perfluorooctane sulfonic acid results in increased expression of GSTM3 mRNA CTD PMID:20936131 more ... perfluorooctanoic acid multiple interactions ISO RGD:62257 6480464 [NR1H3 gene mutant form results in increased susceptibility to perfluorooctanoic acid] which results in increased expression of GSTM3 mRNA more ... CTD PMID:18281256 more ... perfluorooctanoic acid increases expression ISO RGD:62257 6480464 perfluorooctanoic acid results in increased expression of GSTM3 mRNA CTD PMID:18281256 more ... perfluorooctanoic acid affects expression ISO RGD:62257 6480464 perfluorooctanoic acid affects the expression of GSTM3 mRNA CTD PMID:18281256 , PMID:19429403 permethrin increases expression ISO RGD:62257 6480464 Permethrin results in increased expression of GSTM3 mRNA CTD PMID:30629241 phenanthrene multiple interactions ISO RGD:62257 6480464 NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of GSTM3 mRNA] CTD PMID:31181217 phenanthrene increases expression ISO RGD:62257 6480464 phenanthrene results in increased expression of GSTM3 mRNA CTD PMID:31181217 phenobarbital multiple interactions ISO RGD:62257 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA more ... CTD PMID:19482888 more ... phenobarbital increases expression ISO RGD:62257 6480464 Phenobarbital results in increased expression of GSTM3 mRNA more ... CTD PMID:18723825 more ... phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GSTM3 mRNA, Phenobarbital results in increased expression of GSTM3 protein CTD PMID:24418717 , PMID:9794803 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of GSTM3 mRNA CTD PMID:23665940 , PMID:24025784 phenobarbital multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA more ... CTD PMID:23665940 more ... phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of GSTM3 mRNA CTD PMID:18158353 phenytoin multiple interactions ISO RGD:62257 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA CTD PMID:21224054 phlorizin decreases expression ISO RGD:62257 6480464 Phlorhizin results in decreased expression of GSTM5 mRNA CTD PMID:22538082 phlorizin increases expression ISO RGD:62257 6480464 Phlorhizin results in increased expression of GSTM5 mRNA CTD PMID:22538082 picoxystrobin increases expression ISO RGD:1349768 6480464 picoxystrobin results in increased expression of GSTM3 mRNA CTD PMID:33512557 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of GSTM3 mRNA CTD PMID:18544911 , PMID:22484513 piperonyl butoxide multiple interactions EXP 6480464 Piperonyl Butoxide affects the reaction [Phenobarbital affects the expression of GSTM3 mRNA] CTD PMID:24025784 pirinixic acid decreases expression ISO RGD:62257 6480464 pirinixic acid results in decreased expression of GSTM3 mRNA, pirinixic acid results in decreased expression of GSTM5 mRNA CTD PMID:16221962 more ... pirinixic acid multiple interactions ISO RGD:62257 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of GSTM5 mRNA CTD PMID:20813756 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:62257 6480464 Pregnenolone Carbonitrile results in decreased expression of GSTM5 mRNA CTD PMID:18723825 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:62257 6480464 Pregnenolone Carbonitrile results in increased expression of GSTM3 mRNA CTD PMID:18723825 more ... pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:62257 6480464 [Pregnenolone Carbonitrile results in increased activity of NR1I2 protein] which results in increased expression of GSTM3 mRNA, NR1I2 protein affects the reaction [Pregnenolone Carbonitrile results in increased expression of GSTM3 mRNA] CTD PMID:22496397 progesterone affects expression ISO RGD:62257 6480464 Progesterone affects the expression of GSTM5 mRNA CTD PMID:17251523 propanal increases expression ISO RGD:1349768 6480464 propionaldehyde results in increased expression of GSTM3 mRNA CTD PMID:26079696 propiconazole multiple interactions ISO RGD:62257 6480464 NR1H3 gene mutant form promotes the reaction [propiconazole results in increased expression of GSTM3 mRNA] CTD PMID:25949234 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of GSTM3 mRNA CTD PMID:16643972 propiconazole increases expression ISO RGD:62257 6480464 propiconazole results in increased expression of GSTM3 mRNA CTD PMID:21278054 more ... prostaglandin E2 affects chemical synthesis ISO RGD:1349768 6480464 GSTM3 protein affects the chemical synthesis of Dinoprostone CTD PMID:10905636 prostaglandin H2 affects metabolic processing ISO RGD:1349768 6480464 GSTM3 protein affects the metabolism of Prostaglandin H2 CTD PMID:10905636 prostaglandins E affects chemical synthesis ISO RGD:1349768 6480464 GSTM3 protein affects the chemical synthesis of Prostaglandins E CTD PMID:10905636 pyrene increases expression ISO RGD:62257 6480464 pyrene results in increased expression of GSTM3 mRNA CTD PMID:26160115 quercetin decreases expression ISO RGD:62257 6480464 Quercetin results in decreased expression of GSTM3 mRNA, Quercetin results in decreased expression of GSTM5 mRNA CTD PMID:16455785 quinidine decreases expression EXP 6480464 Quinidine results in decreased expression of GSTM3 mRNA CTD PMID:17522070 rac-lactic acid decreases expression ISO RGD:1349768 6480464 Lactic Acid results in decreased expression of GSTM3 mRNA CTD PMID:30851411 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] CTD PMID:21439372 rifampicin multiple interactions ISO RGD:62257 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA CTD PMID:21224054 ritodrine increases expression ISO RGD:62257 6480464 Ritodrine results in increased expression of GSTM3 mRNA CTD PMID:23370008 rotenone increases expression ISO RGD:1349768 6480464 Rotenone results in increased expression of GSTM3 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1349768 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTM3 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1349768 6480464 Silicon Dioxide analog results in decreased expression of GSTM3 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:62257 6480464 sodium arsenite results in increased expression of GSTM5 mRNA CTD PMID:17451858 sodium arsenite decreases expression ISO RGD:1349768 6480464 sodium arsenite results in decreased expression of GSTM3 mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GSTM3 protein CTD PMID:29459688 sodium arsenite affects expression ISO RGD:62257 6480464 sodium arsenite affects the expression of GSTM3 mRNA CTD PMID:16507464 sodium arsenite increases expression ISO RGD:1349768 6480464 sodium arsenite results in increased expression of GSTM3 mRNA CTD PMID:20886546 , PMID:29301061 sodium dichromate increases expression ISO RGD:62257 6480464 sodium bichromate results in increased expression of GSTM5 mRNA CTD PMID:22155349 sodium fluoride decreases expression ISO RGD:62257 6480464 Sodium Fluoride results in decreased expression of GSTM5 mRNA CTD PMID:28918527 sodium fluoride increases expression ISO RGD:62257 6480464 Sodium Fluoride results in increased expression of GSTM5 protein CTD PMID:28918527 Soman decreases expression EXP 6480464 Soman results in decreased expression of GSTM3 mRNA CTD PMID:19281266 spironolactone increases expression ISO RGD:62257 6480464 Spironolactone results in increased expression of GSTM3 mRNA, Spironolactone results in increased expression of GSTM5 mRNA CTD PMID:18723825 stilbene oxide increases expression EXP 6480464 stilbene oxide results in increased expression of GSTM3 protein CTD PMID:9794803 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA more ... CTD PMID:21439372 sulfasalazine increases expression ISO RGD:62257 6480464 Sulfasalazine results in increased expression of GSTM3 mRNA CTD PMID:31830553 sulforaphane increases expression ISO RGD:62257 6480464 sulforaphane results in increased expression of GSTM3 mRNA CTD PMID:17942926 sulforaphane multiple interactions ISO RGD:62257 6480464 [sulforaphane co-treated with dibenzoylmethane] results in increased expression of GSTM3 mRNA CTD PMID:17942926 sunitinib decreases expression ISO RGD:1349768 6480464 Sunitinib results in decreased expression of GSTM3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:62257 6480464 Tamoxifen affects the expression of GSTM3 mRNA CTD PMID:17555576 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of GSTM3 mRNA CTD PMID:15885361 temozolomide increases expression ISO RGD:1349768 6480464 Temozolomide results in increased expression of GSTM3 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases response to substance ISO RGD:62257 6480464 GSTM5 protein results in decreased susceptibility to tert-Butylhydroperoxide CTD PMID:15003993 tert-butyl hydroperoxide increases expression ISO RGD:62257 6480464 tert-Butylhydroperoxide results in increased expression of GSTM5 mRNA CTD PMID:14729362 more ... tetrachloromethane increases expression ISO RGD:62257 6480464 Carbon Tetrachloride results in increased expression of GSTM3 mRNA CTD PMID:27339419 , PMID:29987408 tetrachloromethane affects expression ISO RGD:62257 6480464 Carbon Tetrachloride affects the expression of GSTM3 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions ISO RGD:62257 6480464 PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of GSTM3 mRNA] CTD PMID:16006527 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GSTM3 mRNA CTD PMID:17522070 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of GSTM3 mRNA CTD PMID:16239168 tetracycline decreases activity ISO RGD:1349768 6480464 Tetracycline results in decreased activity of GSTM3 protein CTD PMID:11807801 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of GSTM3 mRNA CTD PMID:17522070 theophylline decreases expression EXP 6480464 Theophylline results in decreased expression of GSTM3 mRNA CTD PMID:17522070 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GSTM3 mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GSTM3 mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO RGD:62257 6480464 titanium dioxide results in decreased expression of GSTM3 mRNA, titanium dioxide results in decreased expression of GSTM5 mRNA CTD PMID:23557971 toluene affects expression EXP 6480464 Toluene affects the expression of GSTM3 mRNA CTD PMID:18653662 toluene 2,4-diisocyanate decreases expression ISO RGD:62257 6480464 Toluene 2 more ... CTD PMID:21404309 triadimefon multiple interactions ISO RGD:62257 6480464 NR1H3 gene mutant form promotes the reaction [triadimefon results in increased expression of GSTM3 mRNA] CTD PMID:25949234 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of GSTM3 mRNA CTD PMID:16643972 triadimefon increases expression ISO RGD:62257 6480464 triadimefon results in increased expression of GSTM3 mRNA CTD PMID:23970803 , PMID:25949234 trichloroethene increases expression ISO RGD:62257 6480464 Trichloroethylene results in increased expression of GSTM3 mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GSTM3 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1349768 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of GSTM3 mRNA] CTD PMID:14575637 trichostatin A increases expression ISO RGD:1349768 6480464 trichostatin A results in increased expression of GSTM3 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO RGD:62257 6480464 trimellitic anhydride results in decreased expression of GSTM3 mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:1349768 6480464 troglitazone results in increased expression of GSTM3 mRNA CTD PMID:19631733 troglitazone decreases expression ISO RGD:1349768 6480464 troglitazone results in decreased expression of GSTM3 mRNA CTD PMID:19631733 tunicamycin decreases expression ISO RGD:62257 6480464 Tunicamycin results in decreased expression of GSTM3 mRNA CTD PMID:17127020 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of GSTM3 mRNA CTD PMID:15885361 valproic acid affects expression ISO RGD:62257 6480464 Valproic Acid affects the expression of GSTM5 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1349768 6480464 Valproic Acid results in increased expression of GSTM3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1349768 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTM3 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:62257 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA CTD PMID:33549593 zinc pyrithione increases expression ISO RGD:1349768 6480464 pyrithione zinc results in increased expression of GSTM3 mRNA CTD PMID:21424779 zinc(0) multiple interactions ISO RGD:62257 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA CTD PMID:33549593
